Results 1 to 10 of about 106,748 (296)

Surface levels of CD20 determine anti-CD20 antibodies mediated cell death in vitro. [PDF]

open access: yesPLoS ONE, 2014
The sensitivity of human Burkitt's lymphoma cells to rituximab (Rtx) and tositumomab (Tst) was assessed on cells expressing different levels of CD20 on surface.
Vijay Singh   +5 more
doaj   +5 more sources

Anti-CD20 monoclonal antibodies: reviewing a revolution

open access: yesHuman Vaccines and Immunotherapeutics, 2018
Since the inception of rituximab in the 1990s, anti-CD20 monoclonal antibodies have revolutionised the treatment of B cell hematological malignancies and have become a cornerstone of modern gold-standard practice.
Stephen Opat
exaly   +2 more sources

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment [PDF]

open access: yesJournal of Hematology & Oncology
Background Baseline CD20 expression ≥ 20% in B-cell acute lymphoblastic leukemia (B-ALL) has been associated with poorer outcomes, which improved after rituximab introduction into frontline therapy for CD20-positive cases.
Monika Szczepanowski   +25 more
doaj   +2 more sources

CD4 and CD20 as important immune markers in patients with pulmonary tuberculosis [PDF]

open access: yesE3S Web of Conferences, 2023
Tuberculosis (TB) is a serious lung infection caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis) is highly contagious, and can be spread through the air from an infected person to others.
Kamoona Firas Mohammad Hussein   +1 more
doaj   +1 more source

Spontaneous Tumor Lysis Syndrome in a Patient with Mantle Zone Cell Lymphoma [PDF]

open access: yesLiaquat National Journal of Cancer Care, 2022
We describe the case of a patient diagnosed to have Mantle cell lymphoma (MCL), who underwent spontaneous tumor lysis syndrome, with overwhelming metabolic acidosis and acute kidney injury, was managed conservatively without the need for hemodialysis ...
Ikram A. Burney, Syed Azhar Rizvi
doaj   +1 more source

Non-Hodgkin lymphoma of cauda equina: A diagnostic conundrum: Case report

open access: yesAdvanced Biomedical Research, 2023
Primary central nervous system lymphoma (PCNSL) is uncommon with scarce cases having involvement of the spinal cord. Cauda equina is unique in its location and shows very rare involvement by diseases pathologies.
Pranati Misra   +5 more
doaj   +1 more source

On the markers for schizophrenia

open access: yesОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2021
Summary. The study of various markers indicating an imbalance in both the neurotransmitter and immune systems observed in patients with schizophrenia is currently of great scientific and practical interest.
A. N. Erichev   +4 more
doaj   +1 more source

Important Diagnostic Clues for Diagnosing Splenic Marginal Zone Lymphoma in Absence of Splenic Histology [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Splenic Marginal Zone Lymphoma (SMZL) is a rare B-cell neoplasm comprising less than 2% of non-Hodgkin lymphomas. We hereby report a case of SMZL in a 66-year-old female who presented with fever and massive splenomegaly.
Anisha Mohanpuria   +4 more
doaj   +1 more source

Ovarian Diffuse Large B-cell Lymphoma Initially Suspected Dysgerminoma Managed by Laparoscopic Staging Surgery

open access: yesGynecology and Minimally Invasive Therapy, 2020
Ovarian diffuse large B-cell lymphoma (DLBCL) is rare. DLBCL is a complex type of lymphoma. The ovarian DLBCL usually harbor a favorable prognosis. We report a case of ovarian DLBCL that presented as an ovarian mass with lower abdominal pain and was ...
Pei- Chen Li   +3 more
doaj   +1 more source

Neolymphogenesis and Immunogistogochemical Study of Lymph Nodes in Breast Cancer

open access: yesКреативная хирургия и онкология, 2020
Background. Our previous studies have shown that postnatally formed lymph nodes (PNFLN) can serve as a source of biological signals activating antitumour immune reactions and suppressing the spread of metastatic malignant cells.Aim.
Sh. Kh. Gantsev   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy